Medtronic (MDT) Gets FDA Approval For Epilepsy Treatment
The Associated Press reported on Friday that a panel at the Food and Drug Administration approved a brain stimulator made by Medtronic Inc. (NYSE: MDT) for the treatment of epilepsy.
The panel voted 7 to 5 in favor of the approval and said that Medtronic must conduct follow-up studies of the brain stimulator to determine whether or not the device is a safe way to treat epilepsy.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Associated Press Food and Drug Administration Medtronic Inc.News FDA Markets
